TY - JOUR
T1 - Protocol for a pilot and feasibility study of nurse practitioner-pharmacist telehealth collaboration to simplify complex medication regimens
AU - Bell, J. Simon
AU - Ooi, Choon Ean
AU - Troeung, Lakkhina
AU - Craik, Sheila
AU - Walton, Rebecca
AU - Martini, Angelita
N1 - Funding Information:
JSB is supported by an NHMRC Boosting Dementia Leadership Fellowship. SC is a nurse practitioner employed by the organization providing residential aged care services to study participants. There are no other conflicts of interest to declare.
Funding Information:
This research study is supported by the Western Australian Nurses Memorial Charitable Trust (Reference Code: WANMCT-Martini_CRAIK-01092020). This funding source had no role in the design of this study and will not involve in the study conduct, data analyses and dissemination of the study findings.
Publisher Copyright:
© 2022
PY - 2022/9
Y1 - 2022/9
N2 - Introduction: New and flexible multidisciplinary workforce models are needed to address unnecessary medication regimen complexity in residential aged care facilities (RACFs). This study will investigate the feasibility of a nurse practitioner-pharmacist telehealth-based collaborative care model to simplify complex medication regimens. Methods: This is a pragmatic, non-randomized pilot and feasibility study of up to 30 permanent residents from 4 RACFs in Western Australia. Simplification will be conducted in accordance with a validated 5-step implicit process. Nurse practitioners will identify residents potentially interested in and who may benefit from simplification, including any regulatory or safety imperatives that might preclude simplification. Medication regimens will be assessed by an off-site clinical pharmacist to identify opportunities for simplification in terms of drug–drug, drug–food, or drug–time interactions, and the availability of alternative formulations. The pharmacist will communicate simplification opportunities to nurse practitioners via video case conferencing. Nurse practitioners will then discuss simplification opportunities with the resident, caregiver and the health and care team, including any unintended consequences for the resident or RACF. The primary outcome measure will be feasibility (stakeholder acceptability, protocol adherence, recruitment and retention rates). Secondary outcomes include change in the number of medication administration times per day, medication and behavioral incidents, falls and fractures, hospitalization and mortality at 4 months. Ethics and dissemination: Ethical approval has been obtained from the Monash University Human Research Ethics Committee. Research findings will be disseminated through industry report, lay summaries, conference presentations and peer-reviewed publications.
AB - Introduction: New and flexible multidisciplinary workforce models are needed to address unnecessary medication regimen complexity in residential aged care facilities (RACFs). This study will investigate the feasibility of a nurse practitioner-pharmacist telehealth-based collaborative care model to simplify complex medication regimens. Methods: This is a pragmatic, non-randomized pilot and feasibility study of up to 30 permanent residents from 4 RACFs in Western Australia. Simplification will be conducted in accordance with a validated 5-step implicit process. Nurse practitioners will identify residents potentially interested in and who may benefit from simplification, including any regulatory or safety imperatives that might preclude simplification. Medication regimens will be assessed by an off-site clinical pharmacist to identify opportunities for simplification in terms of drug–drug, drug–food, or drug–time interactions, and the availability of alternative formulations. The pharmacist will communicate simplification opportunities to nurse practitioners via video case conferencing. Nurse practitioners will then discuss simplification opportunities with the resident, caregiver and the health and care team, including any unintended consequences for the resident or RACF. The primary outcome measure will be feasibility (stakeholder acceptability, protocol adherence, recruitment and retention rates). Secondary outcomes include change in the number of medication administration times per day, medication and behavioral incidents, falls and fractures, hospitalization and mortality at 4 months. Ethics and dissemination: Ethical approval has been obtained from the Monash University Human Research Ethics Committee. Research findings will be disseminated through industry report, lay summaries, conference presentations and peer-reviewed publications.
KW - Medication regimen simplification
KW - Nurse practitioner
KW - Nursing homes
KW - Pharmacist
KW - Residential aged care
KW - Telehealth
UR - http://www.scopus.com/inward/record.url?scp=85128583338&partnerID=8YFLogxK
U2 - 10.1016/j.sapharm.2022.03.010
DO - 10.1016/j.sapharm.2022.03.010
M3 - Article
C2 - 35440429
AN - SCOPUS:85128583338
SN - 1551-7411
VL - 18
SP - 3687
EP - 3693
JO - Research in Social and Administrative Pharmacy
JF - Research in Social and Administrative Pharmacy
IS - 9
ER -